| Protex Healthcare (Uk) Ltd |
| Registered Number:09132651 |
For the year ended 30 December 2024
England and Wales
Unaudited Financial Statements
For the year ended 30 December 2024
Protex Healthcare (Uk) Ltd
Contents Page
1 to 2
Statement of Financial Position
3 to 6
Notes to the Financial Statements
Protex Healthcare (Uk) Ltd
Statement of Financial Position
2023
2024
22,980
31,766
2
| Property, plant and equipment |
135
585
3
110,992
110,992
4
134,107
143,343
-
64,021
5
| Trade and other receivables |
370,613
456,809
6
-
| Cash and cash equivalents |
84
520,914
370,613
| Trade and other payables: amounts falling due within one |
| year |
(195,797)
(212,550)
7
174,816
308,364
Net current assets
| Total assets less current liabilities |
442,471
318,159
| Trade and other payables: amounts falling due after more |
| than one year |
(1,081,790)
(1,192,638)
8
(11,749)
(11,749)
| Provisions for liabilities |
(761,916)
Net liabilities
(775,380)
150
147
581,327
581,327
(1,343,393)
(1,356,854)
(761,916)
(775,380)
Shareholders' funds
| For the year ended 30 December 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the year ended 30 December 2024 in accordance with Section 476 of the Companies Act 2006 |
| The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
| each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
| 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
| statements, so far as applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
1 of 6
For the year ended 30 December 2024
Protex Healthcare (Uk) Ltd
Statement of Financial Position Continued
| VIAENE, Dominiek Noel Director |
| These financial statements were approved and authorised for issue by the Board on 26 September 2025 and were signed by: |
| The notes form part of these financial statements |
2 of 6
For the year ended 30 December 2024
Protex Healthcare (Uk) Ltd
Notes to the Financial Statements
Statutory Information
| Protex Healthcare (Uk) Ltd is a private limited company, limited by shares, domiciled in England and Wales, |
| registration number 09132651. |
Innovation Centre
Gallows Hill
Warwick
CV34 6UW
| The presentation currency is £ sterling. |
Basis of preparing the financial statements
| These financial statements have been prepared in accordance with the provisions of Section 1A of Financial |
| Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the |
| Companies Act 2006. The financial statements have been prepared under the historical costs convention as |
| modified by the revaluation of certain assets. |
| The Directors have confirmed that they will continue to ensure that the company has adequate funding to meet its |
| obligations as they fall due for a period 12 months from the date of approval of these financial statements. |
Revenue recognition
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax or other similar sales taxes. |
Intangible assets
| Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairments losses. Patents and licences are being amortised evenly over their estimated useful life of ten years. |
Property, plant and equipment
| Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: |
Plant and Machinery
Computer Equipment
Inventories
| Inventories are value at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
Deferred tax
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
3 of 6
For the year ended 30 December 2024
Protex Healthcare (Uk) Ltd
Notes to the Financial Statements Continued
| 2. Intangible fixed assets |
45,183
45,183
13,417
8,786
Charge for year
22,203
22,980
31,766
| 3. Property, plant and equipment |
14,309
2,585
11,724
11,724
2,585
14,309
| Provision for depreciation and impairment |
13,724
2,000
11,724
Charge for year
450
450
-
14,174
2,450
11,724
-
135
135
-
585
585
4 of 6
For the year ended 30 December 2024
Protex Healthcare (Uk) Ltd
Notes to the Financial Statements Continued
| 4. Investments held as fixed assets |
110,992
110,992
110,992
110,992
110,992
110,992
110,992
110,992
2023
2024
64,021
-
| 6. Trade and other receivables |
2023
2024
456,809
370,613
| The debtors above include the following amounts falling due after more than one year: |
274,864
222,762
| 7. Trade and other payables: amounts falling due within one year |
2023
2024
22,909
25,738
48,178
58,231
141,463
111,828
212,550
195,797
5 of 6
For the year ended 30 December 2024
Protex Healthcare (Uk) Ltd
Notes to the Financial Statements Continued
| 8. Trade and other payables: amounts falling due after more than one year |
2023
2024
| Bank loans and overdraft (secured) |
33,077
33,077
1,159,561
1,048,713
1,192,638
1,081,790
| 9. Related party transactions |
| During the year management charges of £45,981 (2023: ££72,962) were charged to directors' private companies for |
| work carried out by them on the company's behalf. |
| At the year end in the other creditors there were balances related to directors private companies : MarketMaker of |
| £571,565 Collshaw Consulting £239,999 Andrews Medical & Technical Consultancy Services £114,329 |
| Protex Healthcare (UK) has 100% shares in following companies: Protex Healthcare N.V (Belgian company) and |
| Protex Medical Product LLC (U.S company). |
| £152,109 balance in the other debtors relates to Protex Healtcare N.V. and £27,811 balance relates to Protex |
| Healthcare Nederland BV (Dutch company owned by Protex Healthcare N.V) |
| 10. Average number of persons employed |
During the year the average number of employees was 0
6 of 6